MMedication Read More Summit County’s natural medicine shops offer remedies for any ailmentJuly 26, 2026 Staying at high altitude can be hard on anyone, especially Summit County visitors, who often experience nausea, headaches,…
MMedication Read More FDA OKs pill that combines ingredients of Tylenol, AleveJuly 26, 2026 The Food and Drug Administration approved a new pill that has the active ingredients of Tylenol and competitor…
MMedication Read More Cetirizine hydrochloride tablets recalled after possible contamination raises life-threatening risksJuly 26, 2026 Contamination concerns have prompted a recall of a widely used allergy medicine because the problem could trigger a…
MMedication Read More Women Are More Likely to Get a Job and Find a Partner While on GLP1s, New Study SuggestsJuly 25, 2026 NEED TO KNOW A new study conducted at Harvard University indicates that GLP-1 medications can have an impact…
MMedication Read More New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business OutlookJuly 25, 2026 Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
MMedication Read More Raleigh-area patient hopeful of new FDA-approved cholesterol pillJuly 25, 2026 RALEIGH, N.C. (WTVD) — For nearly two years, Steve Church has been working with doctors to keep his…
MMedication Read More Oral GLP-1 drugs may quiet the brain’s food craving circuitJuly 25, 2026 Popular weight-loss and diabetes medications such as semaglutide and Ozempic belong to a broader group known as GLP-1…
MMedication Read More Rethinking addiction in the age of Ozempic : TED Radio Hour : NPRJuly 25, 2026 GLP-1s could be a breakthrough in addiction treatment. But is medicine alone enough to treat such a complicated…
MMedication Read More FDA Recalls Thyroid Meds Across the USJuly 25, 2026 Thyroid patients are being urged to look closely at their pills after a batch of a widely…
MMedication Read More One in eight U.S. adults uses GLP-1 drugs; Medicare now opens weight-loss access – KOMOJuly 25, 2026 One in eight U.S. adults uses GLP-1 drugs; Medicare now opens weight-loss access KOMOMany US patients opt for obesity…
MMedication Read More FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg)July 25, 2026 FDA-approved first and only OTC fixed‑dose combination of acetaminophen and naproxen sodium, expanding non-opioid options for persistent pain.Addresses…
MMedication Read More New studies reveal rare but real risk of GLP-1 drugsJuly 25, 2026 July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes,…